norstella-logo-white

News & Events

Keep up with the latest news, insights and events from Norstella and its market-leading brands

News | Insights | Events

News

In the News | Mar. 07, 2023

How Robust Data Technology is Transforming the Design and Execution of Viable Clinical Trials

While incorporating real-world data (RWD) and real-world evidence (RWE) across the drug development lifecycle is getting a lot of attention, the application of such insights gleaned from rigorous analysis to the design and execution of clinical trials has yet to be widely adopted, despite its potential to address some of these persistent challenges. Read more
In the News | Jan. 08, 2023

What do you view as the most disruptive or transformational technology or development on the horizon?

Norstella CEO, Mike Gallup, weighs in on the most disruptive / transformational technology on the horizon in a recent pharma’s almanac piece. “As regulators and payers look for new information to guide their decision-making, real-world data and evidence are poised to play a transformative role in not only getting drugs to market quickly, but also ensuring that patients can access them.” Read more
Press Releases | Dec. 09, 2022

Exclusive AIS Health Data Outlines 2021 Compensation for Health Insurer CEOs

Washington, DC, Dec. 9, 2022 — In AIS Health’s annual roundup of health insurer executive compensation data, four newly public startup insurers stand out. But the stock awards that are largely driving their eye-popping total compensation figures — such as Clover Health Investments Corp. CEO Vivek Garipalli’s $390 million or Bright Health Group, Inc. CEO Mike Mikan’s $181 million — are based in part on the firms’ initial public offering (IPO) stock valuations, which were many times higher than what their shares are now worth. Read more
In the News | Nov. 14, 2022

Industry leaders offer reflections on 2022 and predictions for 2023

The COVID-19 pandemic has continued to evolve, forcing companies to adapt to a constantly changing landscape filled with fluid consumer expectations. Meanwhile, several other key healthcare-related trends have bubbled to the surface over that period. Read more
In the News | Nov. 14, 2022

What Can We Expect in Pharma in 2023?

Drug pricing, CMS getting negotiating power for drug purchasing, vaccines, clinical trials, artificial intelligence, and Pharmacists becoming care givers. These are the highlights of 2022, what do the experts say we will see in 2023? We rounded up some experts and asked them just that. And join us for the next few weeks as we look at what we might see in 2023. Read more
In the News | Nov. 14, 2022

The 2023 PharmaVoice Crystal Ball: Peering into the future of life sciences

For the 2023 PharmaVoice Year in Preview, we zeroed in on six key trends: clinical trial diversity, disruptive tech, innovation, talent management, patient engagement and leading through uncertain times. Here, we’ve asked industry execs to look into their crystal balls and tell us about anything they see coming. Read more
Press Releases | Nov. 01, 2022

Citeline and Norstella Complete Merger to Form a $5 Billion Global Pharmaceutical Technology Company

Nov. 1, 2022 – Norstella, a global leader with end-to-end solutions that smooth access to life-saving therapies for patients, has announced the completion of its merger with Citeline (formerly Pharma Intelligence), a leader in the clinical trial intelligence space. At deal close, the $5 billion global company is now one of the world’s largest pharma intelligence solutions providers on the market, with more than 1,600 employees across the five brands that make up Norstella: Evaluate, MMIT, Panalgo, The Dedham Group, and now Citeline. Read more
Press Releases | Jun. 28, 2022

Citeline and Norstella Unite to Offer Life Sciences Clients a Full Suite of Commercial and Clinical Solutions

June 28, 2022 – Norstella, an organization that helps life sciences companies navigate the complexities of the drug life cycle, and Citeline (formerly Pharma Intelligence)—a leading provider of specialist intelligence, data and software for clinical trials, drug development and regulatory compliance—have announced an agreement to merge the companies. Read more
Press Releases | Jun. 23, 2022

MMIT Announces Winners of the Q1 2022 Patient Access Awards

June 23, 2022, Yardley, PA – Managed Markets Insight & Technology (MMIT)—the trusted go-to-market partner for overcoming barriers to patient access—has launched the inaugural Patient Access Awards to honor pharmaceutical manufacturers committed to improving patient access to life-saving therapies. Read more
In the News | Jun. 22, 2022

Merger creates $5 billion pharma technology company

Norstella and Citeline (formerly Pharma Intelligence) have merged to form a $5 billion global company, one of the largest pharma intelligence solutions providers on the market. Read more
In the News | Jun. 22, 2022

Norstella, Citeline merge to create $5bn pharma tech firm

Citeline and Norstella have completed a merger, first announced in June, to create one of the largest players in the pharmaceutical intelligence category. Read more
In the News | Jun. 22, 2022

Norstella completes acquisition of Citeline to form $5B pharma intelligence group

Although financial terms weren’t disclosed, Norstella estimates that it is now a $5 billion player in the market, the company said in a Nov. 1 press release. The acquisition was first announced in June. Read more
In the News | Jun. 22, 2022

Norstella completes merger with Citeline to form $5B pharma tech company

The combined company has more than 1,500 employees worldwide, including about 200 in the Philadelphia region. Read more
In the News | Jun. 22, 2022

Citeline, Norstella complete $5B merger

Citeline and Norstella announced the completion of their $5 billion merger Tuesday morning. The deal, first announced in late June, creates one of the world’s largest pharmaceutical intelligence solutions providers. The combined company has $5 billion and 1,600 employees. Citeline will join four other brands, Evaluate, MMIT, Panalgo and The Dedham Group, as part of Norstella. Read more
Press Releases | May. 09, 2022

MMIT Announces the Winners of the Seventh-Annual Specialty Pharmacy Patient Choice Awards

May 9, 2022, Yardley, PA – Managed Markets Insight & Technology (MMIT)—the trusted go-to-market partner for overcoming barriers to patient access—has announced the winners of the seventh-annual Specialty Pharmacy Patient Choice Awards.  Each year, MMIT hosts the Patient Choice Awards to honor specialty pharmacies that provide best-in-class customer satisfaction and overall patient care within four categories: Payer/PBM, Hospital and Health System, Independent and Retail. Read more
Press Releases | May. 03, 2022

Four prominent pharmaceutical solutions providers launch Norstella to drive innovation and get patients access to life-saving therapies faster

May 3, 2022 – Creating a hub for rapid innovation, four prominent pharmaceutical solutions providers—Evaluate, MMIT, Panalgo and The Dedham Group—are thrilled to announce the launch of Norstella. Read more
Press Releases | Feb. 17, 2022

MMIT Announces Game-Changing Solution for Life Sciences Companies

Feb. 17, 2022, Yardley, PA – Following the acquisition of healthcare analytics company Panalgo in September 2021, Managed Markets Insight & Technology (MMIT) has announced the launch of Patient Access Analytics Read more
Press Releases | Sep. 28, 2021

MMIT/Evaluate Acquire Panalgo

MMIT/Evaluate Acquire Panalgo to Bring Speed and Trust to Pharma Analytics and Decision-Making The move will result in a disruptive, market-leading analytics platform that provides on-demand insights across dozens of normalized real-world evidence and market access data sets that support decision-making from pipeline to prescription September 28, 2021, Yardley, PA — Managed Markets Insight & Technology (MMIT) and […] Read more
Press Releases | Aug. 20, 2021

MMIT and Evaluate

MMIT and Evaluate Join Forces to Offer an End-to-End View of the Pharmaceutical Market Landscape By combining their technology, data and expertise, MMIT and Evaluate will become a $1.6 billion global pharma commercial intelligence provider August 20, 2021, Yardley, PA — Managed Markets Insight & Technology (MMIT), LLC, the trusted go-to-market partner solely focused on solving the “what […] Read more
Press Releases | Apr. 27, 2021

MMIT & The Dedham Group Unite to Smooth Access to Therapy

The combined data, technologies and expertise of both organizations will positively impact patient access to life saving treatments April 27, 2021, Yardley, PA – Managed Markets Insight & Technology, LLC. (MMIT), the trusted go-to-market partner solely focused on solving the “what and why” of market access—so that patients don’t face delays when trying to access lifesaving […] Read more
See more news

Insights

Article | Jan. 30, 2023

Using coverage and claims data provides pharma a view of payer and prescriber behavior

Insufficient return on investment due to an underperforming launch is a thought that makes any pharma manufacturer shudder. Considering that about half of all products launched over the last 15 years have underperformed pre-launch consensus forecasts by more than 20%, companies must proactively plan their near- and long-term strategies to ensure financial losses remain a […] Read more
Article | Jan. 09, 2023

Norstella SMEs Reflect on the Biggest Stories of 2022 and the Industry Trends to Come

Now that 2023 is upon us, now’s the time to gather some key intel from the past year: What did we learn from some of the biggest stories in life sciences? And how can we apply those learnings in the year ahead? To gain some perspective, we tapped SMEs from across the Norstella brands to […] Read more
Article | Dec. 12, 2022

What The Changing Definition Of Patient Access Means For Pharma Manufacturers

By Lindsay Lorenzen VP of Solution Consulting, Norstella The shift away from blockbuster drugs has led the pharmaceutical industry toward more specialized drugs and therapeutic areas for rare diseases, oncology and gene therapy. This wave of specialized, niche therapies has not only necessitated a more in-depth approach to commercialization but also led to increasingly complex […] Read more
Article | Dec. 09, 2022

Health Insurance Startup CEOs’ Sky-High Compensation Figures Are Deceiving

In AIS Health’s annual roundup of health insurer executive compensation data, four newly public startup insurers stand out because their CEOs’ total compensation in 2021 easily outstrips that of chief executives at major firms like UnitedHealth Group and Cigna Corp. However, experts tell AIS Health that the startups’ filings with federal regulators paint an unintentionally […] Read more
See more insights

Events

Conference | March 2023

Reuters Pharma USA

Reuters Pharma USA will be March 28-29 at the Pennsylvania Convention Center. Lindsay Lorenzen, VP Global Solution Consulting will be speaking on the “Fuel your commercial frameworks with a data-driven decision-making engine” panel on March 29. The panel will touch on how to use your rich data sources to champion change management and stay abreast of the complex healthcare environment.
Learn more
Conference | March 2023

Pharma CI Europe

The Pharma CI Conference & Exhibition is THE INDUSTRY’S GOLD STANDARD for senior level pharma, biotech, and device professionals seeking the latest news and the rare chance to network with all the industry’s luminaries.
Learn more
Conference | April 2023

Swiss Biotech Day

The Swiss Biotech Day has become one of the leading biotechnology conferences in Europe and a fixed date in the community’s calendar. In 2022, the conference highlighted the impressive growth of the Swiss biotech industry and presented an exciting program with ideal networking opportunities for over 1,100 participants from across the globe.
Learn more
Conference | April 2023

MassBio State of Possible Conference

MassBio’s State of Possible Conference gives attendees the opportunity to learn from experts, hear from speakers, participate in talks, and expand their professional networks. “Being Bold. Looking Beyond” is this year’s theme with programming spotlighting the state’s global role in advancing science, equity, and patient-driven breakthroughs.
Learn more
Conference | April 2023

Asembia 2023

Meet MMIT at Asembia Specialty Pharmacy Summit, Las Vegas, NV, Apr 30-May 4, 2023. Asembia’s Specialty Pharmacy Summit is at the epicenter of the pharmacy industry, providing a unique opportunity for stakeholders throughout the industry, providing a unique opportunity for stakeholders throughout the industry to understand challenges, generate solutions and define the future.
Learn more
Conference | May 2023

ISPOR Annual

Meet Panalgo at ISPOR, Boston, MA, May 7-10, 2023. ISPOR is the leading global conference for Health Economics and Outcomes Research where healthcare leaders discuss latest trends in HEOR research and healthcare trends.
Learn more
Conference | June 2023

ASCO (Clinical Oncology)

Meet MMIT at the 2023 ASCO Annual Meeting, Chicago, IL June 2-6, 2023. The Annual Meeting is where you can join global cancer experts and discover the latest innovations in cancer research and education. It is a unique opportunity to connect with one of the largest, most diverse audiences in global cancer care.
Learn more
Conference | June 2023

BIO International

The BIO International Convention attracts 14,000+ biotechnology and pharma leaders for one week of intensive networking to discover new opportunities and promising partnerships. Come visit us on stand 2385.
Learn more
Conference | June 2023

AHIP

Meet MMIT at AHIP, Portland, Oregon, June 13-15, 2023. AHIP draws together industry experts, policymakers, academics, and thought leaders to discuss the challenges and opportunities facing the nation’s health care system. The program offers an opportunity to participate in substantive and timely discussions on policy, health plan operations, state issues, and public programs. MMIT will be present at the conference as a sponsor and exhibitor.
Learn more
Conference | June 2023

DIA Global

The DIA 2023 Global Annual Meeting brings together industry, regulatory government, academics, and patients to network, problem-solve, and discuss global and local challenges facing the life sciences community. This year’s conference will take place in Boston, June 25th-29th, 2023. Panalgo will be present at the conference as a sponsor and exhibitor.
Learn more
Conference | October 2023

AMCP Nexus

Meet MMIT at AMCP Nexus, Orlando, Fl, October 16-19, 2023. Nexus brings together a diverse group of payers, pharmacy benefit managers, integrated delivery systems, health economists and analysts, patient advocates, academicians, pharmaceutical manufacturers, and other key stakeholders.
Learn more

Work with us

Join our mission

We're looking for agile, growth-oriented team players who are passionate about client success and helping patients get access to the therapies they need.

Work with us

Get in Touch

Let's connect

Have questions about Norstella or its brands? Or do you want to know more about how to solve your market access challenges?

We want to hear from you